Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
64 hedge funds and large institutions have $9.82M invested in Ampio Pharmaceuticals Inc. in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 8 closing their positions.
76% more call options, than puts
Call options by funds: $72K | Put options by funds: $41K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 71 → 64 (-7)
12% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 17
23% less capital invested
Capital invested by funds: $12.8M → $9.82M (-$2.97M)
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.95M |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$56.4K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
+$29.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$25.5K |
| 5 |
CCMW
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
|
+$18.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.46M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$71.8K |
| 3 |
Morgan Stanley
New York
|
-$71.2K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$70K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$49K |
AMPE Hedge Fund Activity: Q1 2017 in Review
64 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2017, worth a combined $9.82M — down 23% from $12.8M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AMPE and 6 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 15 added.
The largest buyer was BlackRock, adding an estimated $2.95M. The largest seller was Susquehanna International Group, cutting an estimated $1.46M.
- 64 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2017, down from 71 in Q4 2016.
- Funds reported $9.82M of Ampio Pharmaceuticals Inc. stock for Q1 2017, down 23% quarter-over-quarter.
- 6 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2017 and 8 closed out, a net change of -2 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2017 was BlackRock, an estimated $2.95M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2017 was Susquehanna International Group, an estimated $1.46M sold.
Based on aggregated 13F filings for Q1 2017.